Researchers from the Columbia University Department of Neurology discovered a genetic variant that may reduce the odds of developing Alzheimer’s disease by up to 70%.
Sharon Sanz Simon, PhD, Associate Research Scientist in the Gertrude H. Sergievsky Center, discusses the Alzheimer's disease and related dementia in the Brazilian community living in the U.S.
Martin Picard, PhD, Associate Professor of Behavioral Medicine in Psychiatry, Neurology, and the Robert N. Butler Columbia Aging Center is the first to receive the new Baszucki Prize in Science.
Neil A. Shneider, MD, PhD, Claire Tow Associate Professor of Motor Neuron Disorders, is the principal investigator on the grant that will help develop drugs for an underserved portion of ALS patients.
Martin Picard, PhD, associate professor of behavioral medicine, developed a technique that allowed to digitize & quantify the subtle changes in hair color. The gathered data revealed a pattern.
Drs. Bell and Ader will conduct a feasibility study titled, "Intervention to capture the diagnostic potential of individuals in a group-based learning or clinical environment."
Researchers have converted a bacterial toxin into a genome editing tool that, for the first time, can make precise changes to DNA in mitochondria, the cell’s power plants.
The Alzheimer’s epidemic no one is talking about. That’s where the work of Jennifer J. Manly, PhD, a professor of neuropsychology at Columbia University Irving Medical Center, comes in.